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E1 glycoproteinA detailed knowledge of the mechanism of virus entry represents one of the most promising approaches to
develop new therapeutic strategies. However, viral fusion is a very complex process involving fusion
glycoproteins present on the viral envelope. In the two hepatitis C virus envelope proteins, E1 and E2, several
membranotropic regions with a potential role in the fusion process have been identiﬁed. Among these, we
have selected the 314–342 E1 region. Circular Dichroism data indicate that the peptide exhibits a clear
propensity to adopt a helical folding in different membrane mimicking media, such as mixtures of water with
ﬂuorinated alcohols and phospholipids, with a slight preference for negative charged bilayers. The 3D
structure of E1314–342 peptide, calculated by 2D-NMR in a low-polarity environment, consists of two helical
stretches encompassing residues 319–323 and 329–338 respectively. The peptide, presenting a largely apolar
character, interacts with liposomes, as indicated by ﬂuorescence and electron spin resonance spectra. The
strength of the interaction and the deepness of peptide insertion in the phospholipid membrane are
modulated by the bilayer composition, the interaction with anionic phospholipids being among the strongest
ever observed. The presence of cholesterol also affects the peptide–bilayer interaction, favoring the peptide
positioning close to the bilayer surface. Overall, the experimental data support the idea that this region of E1
might be involved in membrane destabilization and viral fusion; therefore it may represent a good target to
develop anti-viral molecules.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Hepatitis C virus (HCV) is amajor public health problemworldwide,
as it is a major cause of chronic hepatitis, cirrhosis, and hepatocellular
carcinoma [1]. Currently there is no vaccine to prevent HCV infection
and the available therapeutic agents not only have limited success but
produce several side effects [2]. A detailed understanding of the
mechanism of HCV virus entry could provide a molecular basis for theholesterol; COSY, correlated
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ll rights reserved.development of new therapeutic strategies [3], however little is known
about the events thatmediatemembrane fusion and cell entry for HCV.
HCV is an enveloped virus that belongs to the hepacivirus genus of the
Flaviviridae family [4]. The viral genome is an approximately 9.6 kb long
single stranded positive RNA molecule that is translated into a
polyprotein precursor of about 3010 amino acids. The precursor is
co- andpost-translationally processed by cellular and viral proteases to
produce at least 10 proteins [5]. The ﬁrst three N-terminal products,
Core and the two envelope glycoproteins E1 and E2, represent the
structural proteins,while the remainingpart of thegenomeencodes for
the non-structural proteins [5]. Among these NS3, NS4 (A and B) and
NS5 (A and B) include all the essential replicative functions, such as the
helicase and the polymerase, and the portion of the viral genome
encoding this proteins can autonomously replicate, as demonstratedby
the establishment of sub-genomic replicons [6]. The small proteins p7
and NS2 separate these two regions. Both proteins have been found
essential for the generation of infectious particles, although their role
and localization remain elusive [7,8].
The two envelope proteins E1 (residues 192 to 383) and E2
(residues 384 to 746 for genotype 1) are essential for receptors binding
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glycosylated in their large N-terminal ectodomains, while are
anchored to the virus membrane by their C-terminal hydrophobic
regions. Through their transmembrane (TM) domains E1 and E2 form
a heterodimer stabilized by noncovalent interactions [11]. This
oligomer is thought to be the prebudding form of the functional
complex [12], which is present at the surface of HCV particles [13] and
is involved in viral entry. Progress in the understanding of viral entry
have been achieved after the establishment of: (a) a retrovirus
expression system generating pseudoparticles carrying HCV glyco-
proteins (HCVpp) [14] and (b) full-length genome based on genotype
2a producing infectious particles in cell culture (HCVcc) [15–17]. The
host membrane spanning protein CD81, previously identiﬁed as
putative HCV receptor [18], has been found to be essential but not
sufﬁcient for infection. The involvement of other identiﬁed candidate
receptors to the mechanism of productive infection, such as SR-BI,
class B, type I scavenger receptor, LDL-R, low density lipoprotein
receptor, and the last identiﬁed Claudin 1 and Occludin [19,20], has
been shown in different situations, but the precise topology of the
event is still lacking. Interestingly, while E2 is the viral protein
responsible for CD81 binding, HCVpp carrying E2 but deprived of E1
are unable to infect cells [9,21]. Thus, E1E2 heterodimer formation, or
an even higher organized structure containing both the proteins, is a
prerequisite for the formation of a functional complex. Viral entry has
been found to be a pH dependent process and it has been supposed
that, analogously to the fusion mechanism of more or less related
viruses, low endosomal pH promotes the rearrangement of E1/E2 to
an active form [22].
Based on the classiﬁcation of HCV in the Flaviviridae family, its
envelope glycoproteins could be included in the class II fusion
proteins [23], however the identiﬁcation of either E1 or E2 as the
HCV fusion protein is still very controversial. Nevertheless, studying
the interaction of peptide libraries of HCV envelope proteins with
model membranes, several regions in E1 and E2 with potential fusion
activity have been identiﬁed, suggesting that distinct segments in the
two glycoproteins can be involved in the fusion process. In particular,
on the E1 glycoprotein, at least three regions, encompassing the
residues 265–296, 310–340 and 349–381 respectively, have been
shown to interact with model membranes [24–26].
These data support the idea that the mechanism of virus fusion is
very complex. Indeed it is already known that, apart from the fusion
peptide, there exist other membranotropic segments along the
sequence of membrane fusion proteins which, under a concerted
action, are essential for membrane fusion [27]. In particular several
studies with viral fusion proteins have shown that the pretransmem-
brane regions play a pivotal role in membrane fusion and viral entry
[28].
Interestingly, the regions proximal to the TM domains, that are
usually rich in aromatic amino acids, demonstrate strong tendencies
to partition into membrane interfaces contributing to the destabili-
zation of the membranes necessary for fusion [29,30]. This has been
widely reported in the literature for class I fusion proteins [31–34].
Another important feature of pretransmembrane regions is that
peptides derived from such domains can also be used to develop
fusion inhibitors, as already shown for the pretransmembrane domain
of gp41 [30].
Although class II fusion proteins present evident differences with
respect to class I ones, it is likely that pretransmembrane domains act
in a similar way, being actively involved in the fusion process [24].
In this work we report the identiﬁcation and structural
investigation of a putative pretransmembrane region of the E1
envelope glycoprotein of HCV. The NMR solution structure of the
peptide has been solved in media mimicking the low-polarity
conditions of the membrane environment and its interaction with
membrane model systems has been studied through CD, ﬂuores-
cence and ESR spectroscopies.The experimental results support the hypothesis that the selected
region of E1 may have a role in the complicated sequence of events
leading to membrane fusion and virus entry.
2. Material and methods
2.1. Materials
The E1314–342 was purchased from the Universitè de Lausanne
(Institut de Biochimie, Ch. Des Boveresses 155, CH-1066-Epalinges).
After puriﬁcation by HPLC, the sample purity was checked by mass
spectrometry and found N95%. SDS, TFE, dichloromethane and
methanol, HPLC-grade solvents, as well as hexaﬂuoroisopropanol
(HFIP) and d2-HFIP were purchased from Sigma.
The phospholipids dioleoyl phosphatidylcholine (DOPC), dioleoyl
phosphatidylglycerol (DOPG), dilauroyl phosphatidylcholine (DLPC)
and dilauroyl phosphatidylglycerol (DLPG), were purchased from
Avanti Polar Lipids. Spin-labeled phosphatidylcholine (n-PCSL) with
the nitroxide group at different positions, n, in the sn-2 acyl chain
were also purchased from Avanti Polar Lipids. The spin-labels were
stored at −20 °C in ethanol solutions at a concentration of 1 mg/ml.
Cholesterol (CHOL) was obtained from Sigma.
2.2. Structure prediction
The secondary structure of E1 was predicted using Jpred3, a
multiple alignment-based consensus method (http://www.compbio.
dundee.ac.uk/~www-jpred/), HNN (http://npsa-pbil.ibcp.fr/cgi-
bin/npsa_automat.pl?page=npsa_nn.html), NNPredict (http://
www.cmpharm.ucsf.edu/~nomi/nnpredict.html), SSPro (http://
www.igb.uci.edu/?page=tools&subPage=psss), SAM-T02 (http://
compbio.soe.ucsc.edu/HMM-apps/T02-query.html) and JUFO
(http://www.meilerlab.org/web/), which are neural networks-
based methods, PHYRE (http://www.sbg.bio.ic.ac.uk/~phyre/) and
PredictProtein (http://www.predictprotein.org/) which are collec-
tions of secondary structure analysis algorithms including PHDhtm
[35], which provides a prediction of transmembrane helices topology.
2.2.1. Circular dichroism
All CD spectra were recorded using a JASCO J-715 spectro-
polarimeter with a cell of 1.0 mm path length. CD measurements
were performed at 298 K, using a wavelength range from 260 to
190 nm, 1 nm bandwidth, 10 accumulations, and 10 nm/min of
scanning speed. The concentration of the peptide in all the solutions
was 0.1 mM. Spectra were processed with JASCO software, baseline
corrected, and smoothed using a third-order least-square polynomial
ﬁt. The secondary structure content was estimated with various
deconvolution methods by using DICHROWEB tools (http://www.
cryst.bbk.ac.uk/cdweb/) [36].
2.3. NMR spectrometry
The samples for NMR spectroscopy were prepared by dissolving
the appropriate amount of peptide in 0.5 ml of solution to obtain a
peptide concentration of 1.0 mM. The composition of the water/d2-
HFIP mixture for NMR measurements was 20/80 by volume.
NMR spectra were recorded on a Bruker DRX-600 spectrometer
equipped with a cryoprobe. One-dimensional (1D) NMR spectra were
recorded in the Fourier mode with quadrature detection, and the
water signal was suppressed by low-power selective irradiation in the
homogatedmode. DQF-COSY, TOCSY, andNOESY experiments [37–40]
were run in the phase-sensitive mode using quadrature detection in
ω1 by time-proportional phase increase of the initial pulse. Data block
sizes were 2048 addresses in t2 and 512 equidistant t1 values. Before
Fourier transformation, the time domain data matrices were multi-
plied by shifted sin2 functions in both dimensions. A mixing time of
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run at 300 K with mixing times in the range of 100–250 ms. The
qualitative and quantitative analysis of NMR spectra was achieved
using the NMRVIEW software [41].
2.4. Structure calculation
Peak volumeswere translated into upper distance boundswith the
routine CALIBA of the CYANA software [42].
The necessary pseudoatom corrections were applied for nonster-
eospeciﬁcally assigned protons at prochiral centers and for themethyl
group of aliphatic side chains. After the redundant and duplicated
constraints were discarded, the ﬁnal list for the structure of E1314–342
in HFIP/water included 386 constraints, which were used to generate
an ensemble of 100 structures by the standard protocol of simulated
annealing in torsion angle space implemented in CYANA (using
10,000 steps). No dihedral angle restraints and no hydrogen bond
restraints were applied. The best 40 structures, the one with the
lowest values of the target functions, were reﬁned by in vacuo
minimization in the AMBER 1991 force ﬁeld, using the program
SANDER of the AMBER 6.0 suite [43]. To mimic the effect of solvent
screening, all net charges were reduced to 20% of their real value, and
a distance-dependent dielectric constant (ɛ=r) was used. The cutoff
for nonbonded interactions was 12 Å. The NMR-derived upper bounds
were imposed as semiparabolic penalty functions, with force
constants of 16 kcal mol−1 Å−2; the function was shifted to linearity
when the violation exceeded 0.5 Å.
2.5. Liposome sample preparation
Liposomes incorporating E1314–342 in the lipid bilayer were
prepared as follows. The peptide was dissolved in HFIP. The lipids
were dissolved in a dichloromethane/methanol mixture (2:1 v/v).
Appropriate amounts of these mother solutions were thoroughly
mixed in round-bottom sample tubes by vortexing. For ESR
measurements small aliquots of the spin-labeled lipid solution in
ethanol were also added to the mixture. A thin ﬁlm of the peptide–
lipid mixture was produced by evaporating the solvent with dry
nitrogen gas. Final traces of solvent were removed by subjecting the
sample to vacuum desiccation overnight. The samples were then
hydrated with the due amount of 50 mM phosphate water solution,
pH 4.5 and vortexed, obtaining a suspension of multi-lamellar
vesicles (MLV), which were directly used for ESR measurements.
To perform CD and ﬂuorescence measurements, small unilamellar
vesicles (SUV), preferred for their lower scattering, were obtained
from multilamellar ones by sonication for 10 min with a Microson XL
instrument equipped with a microtip, alternating 30 s sonication and
30 s ice-cooling to avoid overheating of the sample. By this procedure
E1314–342 was incorporated in liposomes formed by DOPC, DOPG,
DLPC, DLPG, DOPC/CHOL (1:5 molar ratio) and DOPG/CHOL (1:5
molar ratio).
2.6. Fluorescence measurements
Incorporation of the peptide in lipid bilayers was investigated by
monitoring the changes in the Trp ﬂuorescence emission spectra. SUV
samples to be analyzed contained 5×10−6 M E1314–342, and the lipid
at peptide/lipid molar ratio 1:100. Fluorescence measurements were
performed at 25 °C using a Fluorolog-3 spectroﬂuorimeter (Jobin
Yvon). The excitation wavelength was 280 nm and emission spectra
were recorded between 300 and 420 nm, at slit widths of 2 nm.
2.7. ESR measurements
For ESR experiments, MLV dispersions, in the absence and in the
presence of E1314–342, were obtained as described above, andtransferred into a 100 μl glass capillary, which was immediately
ﬂame-sealed. Sample tobeanalyzed contained3×10−3Mphospholipid
and E1314–342 at a peptide/phospholipid mole ratio ranging between
0.004 and 0.2. In all samples, the spin-label content was 1/100 by mole
of the lipid concentration.
ESR spectra were recorded on a 9 GHz Bruker Elexys E-500
spectrometer. The capillaries were placed in a standard 4 mm quartz
sample tube. All the measurements were performed at 25 °C. Spectra
were recorded using the following instrumental settings: sweep
width, 120 G; resolution, 1024 points; time constant, 20.48 ms;
modulation frequency, 100 KHz; modulation amplitude, 1.0 G;
incident power, 6.37 mW. Several scans, typically 32, were accumu-
lated to improve the signal-to-noise ratio. Values of the outer
hyperﬁne splitting, 2Amax, were determined by measuring the
difference between the low-ﬁeld maximum and the high-ﬁeld
minimum, through a homemade, MATLAB-based software routine.
In general, 2Amax is dependent on both the amplitude (i.e., order) and
rate of lipid chain rotational motion [44], and is therefore a useful
parameter for characterizing chain dynamics in phospholipid mem-
branes. The main source of error on the 2Amax value is the uncertainty
in composition of samples prepared by mixing few microliters of
mother solutions. For this reason, reproducibility of 2Amax determi-
nation was estimated by evaluating its value for selected indepen-
dently prepared samples with the same nominal composition. It was
found to be ±0.2–0.3 G.
2.8. Accession codes
The chemical shifts and the coordinates of the E1314–342 peptide
have been deposited in BMRB and PDB databases with accession codes
16477 and 2knu respectively.
3. Results
The region of E1 to analyze was deﬁned by prediction of the
secondary structure of E1 using several methods, including multiple
alignment-based consensus methods, neural networks, and algo-
rithms,whichprovide a prediction of transmembranehelices topology.
All the methods predicted the existence of a region located at the
C-terminal, about 70 residues long, with a helical content ranging
from 50% to 95%, depending on the algorithm used.Within this region,
PHDhtm [35] identiﬁed two transmembrane helices, 18 and 25
residues long respectively, separated by a 5 residues loop. Drawing a
consensus from all the predictions, reported in Fig. 1A, the existence of
three helical regions—H1, H2 and H3—could be hypothesized in the
C-terminal domain of E1. H1 is the shortest and the most hydrophilic
helix, whereas H2 and H3 are more hydrophobic and show the
features of transmembrane helices. The helical wheel representations
of the three helices (Fig. 1B) show that all of them are amphipathic—
although the amphipathic region of H3 is very short, with H1 and H2
showing the highest hydrophobic moments.
Two short sequences in the middle of both H2 and H3—the
sequences RIP and VGN, respectively—showed lower helix propensity
than the surrounding regions and could represent bends or less
regular regions within the two long helices.
On the basis of the predictions we ﬁrst tried to express in E. coli
several constructs encompassing H1, H2 and H3 helices, but
unfortunately we could not obtain a suitable amount of protein,
probably owing to the intrinsic toxicity of these fragments leading
eventually to cellular death (data not shown) [45], therefore we
decided to switch to shorter synthetic peptides. Planning to study the
(pre)transmembrane region of E1, the most logic choice would have
been to synthesize a peptide spanning the whole helices H1 and H2
but, because of the technical difﬁculties in getting the very
hydrophobic peptide enough pure for spectroscopic analysis, we
decided to investigate ﬁrst the structural features and the membrane
Fig. 1. (A) Sequence and secondary structure prediction of the C-terminal region of the E1 protein. The peptide analyzed in this study is shown in bold. Sequence and secondary
structure for the C-terminal region of the M protein of the Dengue virus are shown for comparison. (B) Helical wheel representation of H1 (hydrophobicity=0.68; hydrophobic
moment=0.42), H2 (hydrophobicity=0.71; hydrophobic moment=0.38), and H3 (hydrophobicity=0.94; hydrophobic moment=0.14).
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342 region of E1, spanning the entire H1 helix and the ﬁrst half of helix
H2, up to the low helix propensity-middle region of H2. It is
interesting to notice that this sequence is highly conserved in all
HCV genotypes as reported in the sequence alignment in Table 1.
To characterize the secondary structure of E1314–342, we examined
the far UV-CD spectra in several solvent systems mimicking different
biological environments, represented by saline buffers, SDS micelles
and water/ﬂuorinated alcohols mixtures. In aqueous solution the
peptide is completely soluble only at acidic pH. The spectrum of theTable 1
Sequence alignment of residues 314–342 from reference strains of the six major HCV
genotypes and the E1 preTM sequence used in this work.
Genotype Strain
1a H77C TGHRMAWDMMMNWSPTAALVVAQLLRIPQ
1b NC1 TGHRMAWDMMMNWSPTAALVVSQLLRIPQ
5a SA13 TGHRMAWDMMMNWSPTTALVMAQLLRIPQ
3a NZL1 –GHRMAWDMMMNWSPAVGMVVAHVLRLPQ
2c BEBE1 TGHRMAWDMMMNWSPTTTMLLAYLVRIPE
4a ED43 TGHRMAWDMMMNWSPTTTLVLAQVMRIP–
6a HK TGHRMAWDMMMNWSPTATLVLSSILRVPE
E1preTM 314TGHRMAWDMMMNWSPTAALVVAQLLRIPQ342
Consensus ⁎⁎⁎⁎⁎⁎⁎⁎⁎⁎⁎⁎⁎⁎:. :::: ::⁎:⁎
The residues highlighted in bold are the one whose mutation blocks or reduces viral
entry [65]. The sequence alignment was done with the program CLUSTALW.peptide in acetate buffer, pH 4.5 (Fig. 2A), shows a broad minimum
around 216 nm, suggesting the presence of an extended conforma-
tion. We have also explored the peptide conformation in low polarity
mixtures represented by water and ﬂuorinated alcohols—such as TFE
(data not shown) and HFIP—with different composition, and found in
general a prevailing helical conformation, with the two characteristic
minima around 208 and 222 nm, the helical percentage—calculated as
reported in the methods section—ranging from 20% in the 30/70
water/HFIP mixture up to 25% in the 80/20 mixture. Fig. 2A reports
the CD spectra acquired in water/HFIP 70/30, 50/50 and 20/80 by
volume. A similar percentage of helical content (23%) was found also
in presence of SDS at pH 4.5 (Fig. 2A), whereas the helix amount
decreases at higher pH values. The CD spectra in SDS at different pH
values together with the spectrum in TFE/water 50/50 are reported as
Supplementary material (Figure S1). In order to simulate the bilayer
composition, we considered also a variety of phospholipids (zwitter-
ionic vs. anionic ones, saturated vs. unsaturated ones), eventually in
combination with cholesterol, as it has been shown that cholesterol
play a major role in the fusion process operated by many enveloped
viruses [46] and speciﬁcally by HCV [22]. Concerning the CD curves of
E1314–342 in liposomes, reported in Fig. 2B, the spectrum obtained in
DOPC at pH 4.5 presents a broad minimum around 220 nm, indicating
the presence of an extended conformation. Whereas in the negatively
charged DOPG multilamellar vesicles show the typical minima
associated with helical structures, and a helix content as high as
65% is observed. The CD spectra are not inﬂuenced by the presence of
Fig. 2. (A) CD spectra of E1314–342 in sodium acetate buffer, pH 4.5 (dotted line), HFIP/
water (80:20 v/v) (continuous line), HFIP/water (70:30 v/v) (dashed double dotted
line), HFIP/water (50:50 v/v) (gray dashed-dotted line), SDS 100 mM in phosphate
solution (dashed line), (B) spectra in DOPG vesicles (dashed line), DLPG vesicles
(continuous line), DOPC (dotted line), (C) DOPC/CHOL (dashed line), DOPG/CHOL
(continuous line).
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DLPG is very similar to that in DOPG, with a helical content of around
60% (Fig. 2B).Strikingly, the spectra obtainedwhen cholesterol is added to either
the DOPG and DOPC bilayer (Fig. 2C) are very similar, and suggest that
cholesterol induces a conformational change in the peptide, indepen-
dently on the lipid charge. It is worth to observe that all the
measurements were carried-out at acidic pH in order to be closer to
fusogenic conditions [22].
Overall, the data reported in Fig. 2 indicate that the conformation
of the peptide is strongly dependent on the chemical–physical
features of the environment, as in the case of several other viral TM
domains [47], and that the SDS/negative liposomes interaction and
helical folding requires neutralization of acidic residues, like in the
case of the C-terminal acidic alpha helix of NS4A from HCV [48].
NMR spectra were initially acquired in SDS micelles, pH=4.5,
trying to reproduce a negatively charged micellar environment
similar to that of DOPG vesicles. Unfortunately the quality of NMR
spectra in SDS was very poor, with very broad lines. The same
behavior was observed in the mixture TFE/H2O, probably because the
higher sample concentrations required for NMR experiments favors
the presence of peptide aggregates, thus preventing a detailed
conformational analysis in these conditions. For this reason, on the
basis of the CD data, we selected the HFIP water 80/20 mixture to
study the three-dimensional structure of the peptide in detail, by
using a standard 2D NMR based approach. In these experimental
conditions, based on the spectrum quality, and also in comparison
with previous studies on linear peptides of similar size, we could
conﬁdently assume that the peptide was monomeric.
According to the preliminary CD study, the NOESY spectra show
the typical connectivities of a mainly helical conformation. The
overview of the sequential and medium-range NOE effects in HFIP/
H2O, reported in the bar diagram in Fig. 3A, shows the presence of
several NOEs contacts diagnostic of a helical conformation from
residue 328 to residue 339. In particular, a continuous pattern of dαN
(1,1+3) and d (NN) contacts between residue 332 and 339 indicates
the presence of a α helical structure, although the presence in the
same region of dαN(i, i+2) contacts suggests the presence of mixed
helical conformations. On the other hand several NOE effects
diagnostic of helical structures are present also in the region
encompassing residues 328–331, suggesting the hypothesis of a
continue helix from Pro328 to Arg 339, but some breaks due to peaks
overlap prevented the possibility to detect unambiguously the NOE
involving residues 329–331.
Another small helical turn is present between residue Trp 320 and
Met 323 and a few NOEs diagnostic for a helical conformation are
present also between His 316 and Ala 319, but the severe signal
overlapping at the N-terminus prevented the possibility to identify
clearly a helical conformation. The region between Met 324 and Ser
327 does not showNOEs diagnostic of any ordered conformation; thus
the whole structure can be described as a helix-break-helix motif.
To obtain information about the solvent exposure of the single
residues, we performed a deuterium exchange experiment by
dissolving the freeze-dried peptide directly into an 80/20 HFIP/D2O
mixture. The TOCSY spectrum acquired after 12 h indicated that the
amide protons of residues from Ala 330 and Leu 338 were still
detectable in solution, whereas all the remaining signals disappeared
completely. This result, reported also in the bar-diagram, suggests
that between the two helical stretches, the one at the N terminus is
more ﬂexible and in fast deuterium exchange regime, whereas the
helix at the C terminus is more rigid.
To check for the presence of proline isomerization we analyzed
connectivities between Ser 327 and Pro 328 and between Ile 340 and
Pro 341. The dαα(i,i+1) cross-peaks, typical for the cis conformer,
weremissing,whereaswe could observe dαδ(i,i+1) connectivities for
both prolines, indicating that they are both in a trans conformation.
The whole set of 386 NOE derived distance constraints was used as
input for structure calculation, as described in detail in the experi-
mental section. From the 100 structures calculated the 40 with the
Fig. 3. (A) Bar diagram reporting the sequential and medium range NOE effects in the NOESY spectra recorded in the HFIP/H2O (80:20) mixture at 298 K, the ﬁlled circles indicate
residues whose amide protons do not exchange with deuterium after 24h. (B) 1Hα chemical shift differences versus peptide sequence. The differences were calculated subtracting
the experimental values to the random coli conformation values reported by [67]. (C) NOE contacts between the side chains of Trp 326 and PRO 328 and ALA 331 respectively in the
100 ms NOESY 2D spectrum. (D) Bundle of the best 10 structures calculated of the E1314–342. In yellow are shown the side chains of Trp 326, Pro 328 and Ala 331. (E) Electrostatic
surface representation of the lowest energy structure of the E1314–342 peptide.
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bundle of the 10 lowest energy structures resulting from this
procedure, shown in Fig. 3D, was selected as representative of the
solution structure of the E1314–342 peptide, a structural statistics table
of the calculated ensemble is presented as supplemental material. The
best ﬁt between the structures was found when the more ﬂexible N
and C terminal residues were excluded, i.e. between Met 318 and Leu
338. To give an idea of the structure quality, the calculated RMSDof the
backbone atoms and of all heavy atoms for the 10 lowest energy
structures, were 0.52 and 0.89 Å, respectively.
According to the qualitative analysis based on the bar-diagram, the
reﬁned structure can be described as two helical stretches, a short one
spanning from Ala 319 to Met 323 and a second, longer helix from Thr
329 to Leu 338. Unfortunately the great number of overlapping signals
in N-terminal part does not allow a better deﬁnition of this region, but
the presence of a longer helical segment cannot be excluded as
suggested from the difference between the measured Hα chemical
shift and the random coils reported in Fig. 3B. The two helices are
interrupted by a bend centered on Trp 326. This region is very well
conserved in all the conformers and is mainly stabilized from side
chain contacts like the one between the side chains of Trp 326 and Pro
328, and Trp 326 and Ala 331 (some of them are shown in Fig. 3C).
Despite the fact that the HFIP/H2O solution does not favor
hydrophobic interaction, many NOE contacts between these sidechains are observed, also at low mixing times, suggesting that these
conformers are highly populated.
The analysis of the electrostatic potential surfaces (Fig. 3E)
indicates that the helical region is mainly hydrophobic, with almost
all the charged residues located near the N-terminus. This organiza-
tion suggests that at least part of the peptide could easily interact with
membrane double layer.
To evaluate the membrane interaction tendency of E1314–342 we
used tryptophan ﬂuorescence spectroscopy. Indeed the ﬂuorescence
intensities of some ﬁne vibronic structures in the tryptophan
spectrum show strong environmental dependence [49,50]. In partic-
ular, the emission maximum shifts from 350 to 329 nm when going
from water to an apolar medium such as dioxane [49]. The quantum
yield might also undergo large changes whose direction and extent
depend on the system under consideration [51]. Consistently, the
ﬂuorescence experiments allow evaluating if E1314–342 is embedded in
the DOPC, DOPG, DOPC/CHOL and/or DOPG bilayer by measuring a
change in the polarity experienced by the tryptophans.
As shown in Fig. 4, E1314–342 in buffer presents a Trp emission
spectrum typical of the aqueous environment (λmax=348 nm),
indicating that both Trp are exposed to the aqueous medium. In DOPC
and, even more, in DOPG SUV dispersions, the emission maximum is
shifted to lower wavelength (λmax=340 nm for DOPC and 333 nm for
DOPG), indicating the peptide tryptophans to be embedded in a less
Fig. 4. (A) tryptophan emission spectra of E1314–342 in aqueous medium at pH 4.5 (solid
line), and in the presence of DOPC (dashed line), DOPG (dotted line) liposomes. (B)
Tryptophan emission spectra of E1314–342 in aqueous medium at pH 4.5 (solid line), and
in the presence of DOPC/CHOL (dashed line), DOPG/CHOL (dotted line) liposomes.
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evidences indicate that the peptide is effectively incorporated in the
lipid bilayer. In contrast, in DOPC/CHOL and DOPG/CHOL SUV
dispersions the emission maximum remains at values very close to
that observed in water (λmax=348 and 349 nm, respectively), an
evidence that the peptide's tryptophans are exposed to the aqueous
medium. In all cases, the quantum yield increases; this effect was
already observed for other peptides, derived from fusion glycopro-
teins, interacting with model membranes [24,52–54].
Analogously to the CD spectra, the ﬂuorescence spectra are not
inﬂuenced by the presence of unsaturations along the phospholipid
acyl chains, as the spectra in DOPC and DLPG are very similar to those
observed in DOPC and DOPG, respectively (spectra not shown).
The association of the E1314–342 with the membranes was further
investigated by ESR spectroscopy. This technique requires the
presence of unpaired electrons in the systems to be investigated. In
ESR silent systems, spin-labeled substances can be purposely
introduced. Cyclic nitroxides are very often used as spin-labeling
moieties due to their remarkable stability. Analysis of their spectra
allows to investigate the polarity of the microenvironment in which
the label is embedded and restrictions in its motion determined bymicroviscosity and/or by speciﬁc interactions with the system
components. This approach has proved to be fruitful to the study of
the interactions between peripheral as well as integral proteins and
membranes. Either the protein/peptide or the lipid can be labeled, so
that the system can be studied by different “points of view” [55].
Particularly, ESR spectroscopy of spin-labeled lipids is a well assessed
method, developed by Marsh et al. [56–58], allowing to evaluate the
perturbation of the lipid chain mobility due to proteins/peptides
interaction with the membrane. Good results are usually obtained by
using bilayers in the ﬂuid-phase state [59] because changes in the
lipid mobility due to the interaction are enhanced.
In the present work we have investigated spin-labeled phospha-
tidylcholines (n-PCSL) incorporated in either DLPC or DLPG mem-
branes, in the absence and in the presence of the peptide E1314–342
(1:10 mol/mol peptide to lipid ratio). At room temperature, both
DLPC and DLPG bilayers are in the ﬂuid-phase state [60]. The n-PCSL
spectra in the zwitterionic and the anionic lipid samples are shown in
Fig. 5A and B, respectively. In general, a nitroxide ESR signal presents
three hyperﬁne lines, due to the coupling between the electron spin
and the nuclear spin of the nitrogen atom. Insertion of the label in a
locally oriented ordered environment such as a membrane causes the
appearance of a spectral anisotropy, detectable by the splitting of the
lateral lines. Inspection of the ﬁgures shows that, for both lipids, in the
absence of peptide, the spectrum anisotropy becomes progressively
less evident with increasing n, as the spin-label position is stepped
down the chain toward the center of the membrane. In fact, as
opposed to the clearly deﬁned axially anisotropic spectra that are
obtained for 5-PCSL, where the label is positioned on the acyl chain
close to the phospholipid polar headgroup, a sharp, three-line, quasi-
isotropic spectrum is obtained for 12-PCSL, bearing the label close to
the terminal methyl region of the chain. This ﬂexibility gradient is a
characteristic hallmark of the liquid-crystalline state of ﬂuid phos-
pholipid bilayers [58]. In Fig. 5A slight, but signiﬁcant perturbations in
DLPC bilayers due to the presence of E1314–342 are detectable.
Spectrum anisotropy increases in all cases, except for 12-PCSL.
Inspection of Fig. 5B reveals much stronger effects of the E1314–342
insertion in DLPG bilayers. The perturbation is evident for all the spin
labels; particularly, in the case of 12-PCSL there is an appearance of a
second, more motionally restricted component, indicating that the
peptide penetrates appreciably into the membrane interior.
The outer hyperﬁne splitting, 2Amax, is a reliable and easy-to-
perform estimate of the segmental chain mobility. 2Amax is deﬁned as
separation, expressed in gauss, between the low-ﬁeld maximum and
the high-ﬁeld-minimum, and tends to increase with increasing the
restriction in local chain mobility. Fig. 6 shows that, for the n-PCSL spin
labels in DLPC and DLPG bilayers, 2Amax decreases with increasing n.
Inspection of the ﬁgure also shows that, although the characteristic
ﬂexibility gradient with chain position of the ﬂuid lipid bilayer
membranes is preserved, the presence of bound E1314–342 causes an
increase which depends on the bilayer charge. Particularly, in DLPC
membranes 2Amax increases to roughly the same extent (∼2 G), at all
spin-label chain positions except the deeper one. The 2Amax increase
due to peptide is much higher than in DLPGmembranes (∼6 G, see Fig.
6A), and moreover is of the same extent at all the spin-label positions,
included todeeper one.When comparedwith several different proteins
or polypeptides analyzed in a recent publication [52], the increase of
2Amax due to the penetration of E1314–342 in an anionic bilayer was
among the higher ever registered, highlighting a strong interaction and
a deep penetration of this peptide in the DLPG bilayer structure.
In order to estimate the stoichiometry of the E1–DLPG interaction
we determined the increase in outer hyperﬁne splitting, 2ΔAmax, of
the 5-position spin-labeled lipids in DLPG membranes as a function of
peptide concentration (Fig. 6B). A typical saturation trend is
registered: the decrease in lipid chain mobility saturates with a
value of 2ΔAmax ≈ 6 G at a mole ratio of added E1 to DLPG of
approximately 0.08, which corresponds to approximately 12 lipid
Fig. 5. ESR spectra of n-PCSL positional isomers in DLPC (A) and DLPG (B) bilayer membranes, in the presence (red line) and absence (black line) of 1:10 (mol/mol) E1314–342.
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estimated alternatively by extrapolation of the increase in 2ΔAmax, on
initial tight binding, to the saturation value of 2ΔAmax. This gives a value
of one E1molecule bound per 25 lipidmolecules. However it should be
considered that the latter is likely to be an upper estimate because of a
possible nonlinear dependence of 2ΔAmax on peptide binding.
4. Discussion
Infection of eukaryotic cells by enveloped viruses requires the
fusion of the viral and plasma or endosomal membranes. Highly
speciﬁc viral envelope glycoproteins catalyze this reaction, thus
overcoming its inherent energy barriers. Although the fusion peptide
is reported to be themajor responsible for the ﬁrst steps of membrane
fusion, other segments of these glycoproteins are indispensable to
drive and accomplish the process. Pretransmembrane (PTM) regions,
in particular, seem to play an important role as promoters of
phospholipid bilayer destabilization, providing a way to lower the
energy barrier necessary to fusion [30,33]. The region of the E1
glycoprotein between residues 309 and 340, located in close proximity
of the TM domain, is highly conserved in all strains of HCV and is
proposed to be involved in membrane destabilization, as well as inFig. 6. (A) Dependence on spin-label position, n, of the outer hyperﬁne splitting, 2Amax,
of the n-PCSL in: DLPC membranes in the absence (■) and presence (□) of 1:10
(mol/mol) E1314–342 and DLPGmembranes in the absence (●) and presence (○) of 1:10
(mol/mol) E1. (B) Dependence of the increase, 2ΔAmax, in outer hyperﬁne splitting of
5-position phospholipid spin labels on the peptide/lipid ratio for E1314–342 in DLPG
bilayer membranes.pore formation and enlargement, in a manner similar to that of the
pretransmembrane and/or loop domains of class I fusion proteins [24].
In this paper we have solved for the ﬁrst time the NMR structure of
a peptide corresponding to the 314–342 region of the E1 glycoprotein
and, combining several spectroscopic techniques, we have studied his
behavior in membrane mimicking media. A preliminary conforma-
tional analysis carried out by CD measurements in different
experimental conditions suggested that the peptide exhibits a clear
propensity to adopt a helical folding in membrane mimicking media
with a slight preference to negative charged bilayers.
Tryptophan ﬂuorescence spectra show that the peptide interacts
with anionic and zwitterionic phospholipid membranes. In presence
of anionic phospholipids the peptide is better incorporated into the
membranes whereas in the presence of cholesterol the peptide tends
to adsorb on the surface of cholesterol enriched bilayers, indepen-
dently on their charge.
ESR spectra allowed us a more accurate evaluation of the
membrane interaction and insertion of the E1 region selected. The
analysis of the ESR data indicates a strong interaction and deep
penetration of this peptide in the bilayer structure of the membrane,
both in the case of anionic and zwitterionic phospholipid, probably due
to the largely apolar character of the peptide structure. Moreover, the
interaction with anionic phospholipids is among the strongest ever
observed, not only when comparing the data obtained for the same
peptide in presence of zwitterionic phospholipids, but also when
considering the interactions of several othermembrane active proteins
and peptides with anionic multilamellar phospholipids [56]. These
results indicate that the peptide deeply penetrates the membrane.
According to the CD data, E1314–342 peptide in a low polarity
environment assumes a partial ordered structure, with a large α-
helical character. Among the different experimental conditions
explored, we obtained suitable NMR spectra only in the HFIP/H2O
(80/20 v/v), a low polarity mixture that can reproduce an
environment close to the inner membrane. It is worth to consider
also that this medium represents a good compromise between
chemical physical conditions and quality of experimental data, and
that was already used to solve the solution structure of other
membrane-interacting peptides, including the Amyloid β-peptides
A-β-(1–42) and A-β-(25–35) [61,62].
The structure calculated out of the 386 NMR constraints shows two
helical stretches encompassing residues 319–323 and 329–338,
respectively, interrupted by a break deprived of any canonical
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in all the conformers resulting from the structure calculation
procedure and is stabilized by a dense network of contacts between
the side chains of Trp 326 and Pro 328, and Trp 326 and Ala 331
respectively. It is not new that peptides derived from fusion proteins
assume a bended structure in solution, for example, it has been shown
that the “ﬁxed angle boomerang structure” of the fusion peptide of
inﬂuenza hemaglutinin is required to support membrane fusion
sufﬁcient to anchor the fusion domain in the proper conformation in
the interface of the lipid bilayer [63]. Even more interestingly it was
proved that a tryptophan residue is involved in the stabilization of the
structure through hydrophobic interactions [64]. Obviously, further
experiments will be required to conﬁrm that the bended structure of
the E1 peptide is also important for viral entry.
It is also interesting to notice that the second helical stretch
(between residues 329 and 338) includes a conserved hydrophobic E1
heptad repeat region (see Table 1) whose mutation is reported [65] to
affect dramatically viral entry, while the E1 and E2 heterodimerization
is not hampered. More in detail, the mutations V333P L337P
completely blocked virus entry while the mutation of the same
residues into alanine resulted in a site-speciﬁc entry defects. These
data, combined with our structure, suggest that the helical confor-
mation is an essential prerequisite for virus entry.
Interaction of domains of the fusion proteins with both the
juxtaposed membranes (the viral membrane and that of the target
cell) is fundamental for their fusion. Penetration and/or adsorption of
peptidic sequences into/onto the lipid bilayer, like those found in the
present work, causes a membrane stress, often related to a
perturbation in the packing of the lipid molecules [66]. In lack of
any datum on the E1 conformational changes and lipid membranes
rearrangements during the fusion process, one cannot discriminate
which is the membrane the peptide investigated in the present work
interact with. Particularly, because of its closeness to the protein TM
domain, one cannot exclude that it exerts its main role in the process
by interacting with the viral membrane rather then with that of the
target cell. Further studies are necessary to clarify this point.
Overall, the structural features and the entrance of the E1314–342
peptide in the phospholipids membranes are in agreement with the
hypothesis that this region of E1 might play an essential role in
membrane fusion, maybe involved in pore formation and enlarge-
ment as it has been suggested for class I fusion proteins [25] and
consequent viral entry. Furthermore, despite the high variability of
HCV envelope protein sequence, this domain of E1 is conserved
among the different genotypes, becoming an optimal target for the
development of anti-viral molecules.
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